ALV vs DDS

Autoliv (ALV) shows mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score to assess distress risk. The stock appears reasonably valued with a P/E of 13.03 below sector average, strong ROE of 31.01%, and solid earnings growth of 31% YoY, but faces concerns around liquidity (Current Ratio: 0.95) and technical weakness (Technical Trend: 10/100). Dividend strength is moderate at 50/100 with a sustainable 2.48% yield, while analyst consensus leans positive with a $138.72 target price. However, insider sentiment is lukewarm and recent price performance shows decelerating momentum despite solid long-term returns.

DDS exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.31. However, the stock is significantly overvalued, trading at $595.20—nearly double its Graham Number ($305.57) and Intrinsic Value ($255.01). While profitability remains high with an ROE of 31.90%, the company is facing a growth stagnation with negative YoY revenue and earnings growth. The disconnect between strong fundamental health and poor valuation/growth metrics suggests a limited upside from current levels.